首页> 外文期刊>Spine >Calcitonin enhanced lumbar spinal fusion in a New Zealand rabbit model: A study with morphologic and molecular analysis
【24h】

Calcitonin enhanced lumbar spinal fusion in a New Zealand rabbit model: A study with morphologic and molecular analysis

机译:降钙素增强的新西兰兔模型腰椎融合术:形态学和分子分析研究

获取原文
获取原文并翻译 | 示例
           

摘要

Study Design.: In this study, the effect of calcitonin on lumbar spinal fusion was studied in a New Zealand rabbit model. Objective.: To investigate whether calcitonin can enhance lumbar spinal fusion in a New Zealand rabbit model and whether calcitonin can enhance expression genes involved in osteogenesis and angiogenesis. Summary of Background Data.: Calcitonin is used to treat osteoporosis and diseases involving accelerated bone turnover. Studies have shown that calcitonin might also promote bone cell proliferation and bone formation, suggesting its possible role in promoting spinal fusion, but few data are available. Methods.: The effect of calcitonin on lumbar spinal fusion was analyzed in 32 New Zealand rabbits. Each rabbit received 2 autologous iliac bone grafts (one between L4-L5 without fixation, one between L6-L7 with fixation). Sixteen rabbits received calcitonin (calcitonin group, 1 U/kg daily from day 1 to the day of sacrifice), whereas the other 16 did not (control). At weeks 1, 2, 4, and 8, after examination for spinal fusion with radiography, 4 rabbits from each group were sacrificed. Each graft was histologically scored under light microscopy. In addition, we analyzed the messenger RNA (mRNA) levels of collagen I (Col I), bone morphometric protein 2 (BMP-2), insulinlike growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF), genes known to be involved in osteogenesis and angiogenesis, in each graft. Results.: With both fixation and without fixation, the bone grafts in rabbits receiving calcitonin showed a higher spinal fusion rate and higher histologic scores from week 2 to week 8, and had higher mRNA levels of Col I, BMP-2, IGF-1, and VEGF at all time points except BMP-2 and IGF-1 at week 1, than grafts in rabbits without receiving calcitonin. Conclusion.: Calcitonin can enhance lumbar spinal fusion. One mechanism might be through upregulating genes involved in osteogenesis and angiogenesis.
机译:研究设计:在本研究中,在新西兰兔模型中研究了降钙素对腰椎融合的作用。目的:研究降钙素是否可以增强新西兰兔模型的腰椎融合以及降钙素是否可以增强涉及成骨和血管生成的表达基因。背景数据摘要:降钙素用于治疗骨质疏松症和涉及骨代谢加速的疾病。研究表明降钙素也可能促进骨细胞增殖和骨形成,表明其可能在促进脊柱融合中发挥作用,但目前尚无数据。方法:在32只新西兰兔中分析降钙素对腰椎融合的作用。每只兔子接受2个自体骨移植物(一个在不固定的L4-L5之间,一个在不固定的L6-L7之间)。 16只兔子接受降钙素治疗(降钙素组,从第1天到处死当天每天1 U / kg),而其他16只则不接受(对照)。在第1、2、4和8周用放射线照相检查脊柱融合后,处死每组4只兔子。在光学显微镜下对每个移植物进行组织学评分。此外,我们分析了胶原蛋白I(Col I),骨形态计量蛋白2(BMP-2),胰岛素样生长因子-1(IGF-1)和血管内皮生长因子(VEGF)的信使RNA(mRNA)水平,每个移植物中都已知与成骨和血管生成有关的基因。结果:在有固定和无固定两种情况下,接受降钙素治疗的兔的骨移植物从第2周到第8周显示出更高的脊柱融合率和更高的组织学评分,并且具有较高的Col I,BMP-2,IGF-1 mRNA水平第1周的BMP-2和IGF-1除外的所有时间点的VEGF和VEGF均高于未接受降钙素的兔的移植。结论:降钙素可增强腰椎融合。一种机制可能是通过上调涉及成骨和血管生成的基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号